Similar Search Results

Measuring Quality of Life in Patients with Schizophrenia: An Update

Awad, A. George.; Voruganti, Lakshmi N.P. - In: PharmacoEconomics 30 (2012) 3, pp. 183-195

In 1997, we published a review in PharmacoEconomics about quality of life (QOL) measurement in patients with schizophrenia. The objective of this article is to provide an update, as well as to revisit the development of the construct of QOL and its measurement as applied to schizophrenia. Since...

Persistent link: https://www.econbiz.de/10009493379

The Authors' Reply

Awad, A. George.; Voruganti, Lakshmi N.P. - In: PharmacoEconomics 30 (2012) 6, pp. 532-533

Persistent link: https://www.econbiz.de/10010548282

The Lack of Impact of Quality-of-Life Measures in Schizophrenia: A Shared Responsibility?

Boyer, Laurent; Auquier, Pascal - In: PharmacoEconomics 30 (2012) 6, pp. 531-532

Persistent link: https://www.econbiz.de/10010548285

Valuation of the Child Health Utility 9D Index

Stevens, Katherine - In: PharmacoEconomics 30 (2012) 8, pp. 729-747

Background and Objectives:Background and Objectives: The aim of this study was to test the feasibility of estimating preference weights for all health states defined by the Child Health Utility 9D (CHU9D), a new generic measure of health-related quality of life for children aged 7-11 years. The...

Persistent link: https://www.econbiz.de/10010556690

Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders: A Comparison of Generic Instruments

Tilford, J. Mick.; Payakachat, Nalin; Kovacs, Erica; … - In: PharmacoEconomics 30 (2012) 8, pp. 661-679

Background:Background: Cost-effectiveness analysis of pharmaceutical and other treatments for children with autism spectrum disorders (ASDs) has the potential to improve access to services by demonstrating the value of treatment to public and private payers, but methods for measuring QALYs in...

Persistent link: https://www.econbiz.de/10010556691

Valuing Children's Health: Whose Quality of Life Matters?

Wittenberg, Eve - In: PharmacoEconomics 30 (2012) 8, pp. 633-635

Persistent link: https://www.econbiz.de/10010556693

A Parent-Child Dyad Approach to the Assessment of Health Status and Health-Related Quality of Life in Children with Asthma

Ungar, Wendy J.; Boydell, Katherine; Dell, Sharon; … - In: PharmacoEconomics 30 (2012) 8, pp. 697-712

Background:Background: Assessment of health state and health-related quality of life (HR-QOL) are limited by a child's age and cognitive ability. Parent-proxy reports are known to differ from children's reports. Simultaneous assessment using a parent-child dyad is an alternative approach....

Persistent link: https://www.econbiz.de/10010556694

Assessing Quality of Life among British Older People Using the ICEPOP CAPability (ICECAP-O) Measure

Flynn, Terry N.; Chan, Phil; Coast, Joanna; Peters, Tim J. - In: Applied Health Economics and Health Policy 9 (2011) 5, pp. 317-329

Background: The Investigating Choice Experiments for the Preferences of Older People (ICEPOP) programme developed a capability-based measure of general quality of life (QOL): the ICEPOP CAPability (ICECAP-O) instrument. ICECAP-O was originally intended for use in the economic evaluation of...

Persistent link: https://www.econbiz.de/10010614257

QALYs and Carers

Al-Janabi, Hareth; Flynn, Terry N.; Coast, Joanna - In: PharmacoEconomics 29 (2011) 12, pp. 1015-1023

When going 'beyond the patient', to measure QALYs for unpaid carers, a number of additional methodological considerations and value judgements must be made. While there is no theoretical reason to restrict the measurement of QALYs to patients, decisions have to be made about which carers to...

Persistent link: https://www.econbiz.de/10010614320

Understanding and Assessing the Impact of End-Stage Renal Disease on Quality of Life: A Systematic Review of the Content Validity of Self-Administered Instruments Used to Assess He...

Glover, Cheryl; Banks, Pauline; Carson, Amanda; Martin, … - In: The Patient: Patient-Centered Outcomes Research 4 (2011) 1, pp. 19-30

Advances in healthcare, combined with an increasing number of adults with end-stage renal disease (ESRD), mean that there is a growing number of people now surviving on renal replacement therapy. The issue of health-related quality of life (HR-QOL) is becoming increasingly important in this...

Persistent link: https://www.econbiz.de/10010614413